Neuraxpharm and partner Minoryx Therapeutics, meanwhile, were unable to convince the CHMP that they should get conditional approval for PPAR gamma agonist Nezglyal (leriglitazone) as a treatment ...

The CHMP has backed the drug as a treatment for FA in patients aged 16 years and older, a few months after Skyclarys (omaveloxolone) was approved by the FDA for the same indication, and shortly ...

After hours: March 24 at 7:55:47 PM EDT Loading Chart for IX ...

Found the Hyundai ix35 of your dreams? Now you want to know all about it! With the help of Parkers, you can find out all of the key specs about the Hyundai ix35 from fuel efficiency in MPG and top ...

21 March 2025 China's burgeoning biotech R&D capabilities are attracting increasing international attention, with non-Western countries actively seeking partnerships. At the BIOCHINA event in Suzhou ...